PC
LAB icon

Polar Capital’s Standard BioTools LAB Stock Holding History

Polar Capital’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-54,132
Closed -$489K – 266
2016
Q2 		$489K Sell
54,132
-10,360
-16% -$97.4K 0.01% 253
2016
Q1 		$520K Buy
64,492
+13,775
+27% +$99.3K 0.01% 250
2015
Q4 		$548K Buy
50,717
+26,622
+110% +$261K 0.01% 246
2015
Q3 		$195K Sell
24,095
-866
-3% -$13.6K ﹤0.01% 270
2015
Q2 		$604K Buy
24,961
+6,280
+34% +$198K 0.01% 266
2015
Q1 		$786K Sell
18,681
-1,513
-7% -$59.8K 0.01% 256
2014
Q4 		$681K Buy
20,194
+5,460
+37% +$155K 0.01% 253
2014
Q3 		$361K Buy
14,734
+2,898
+24% +$81.5K 0.01% 253
2014
Q2 		$348K Buy
+11,836
New +$379K 0.01% 255

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Polar Capital's LAB Position: Q3 2016 in Review

Polar Capital sold out of Standard BioTools (LAB) in Q3 2016, closing a stake of 54,132 shares — an estimated $489K sold.

Polar Capital first reported a position in LAB in Q2 2014 and held it in 9 quarters. The position peaked at $786K in Q1 2015. 98 funds tracked by Wall St. Rank hold LAB as of Q3 2016.

  • Polar Capital reported no remaining Standard BioTools position as of Q3 2016 after selling out during the quarter.
  • Polar Capital sold 54,132 Standard BioTools shares in Q3 2016, an estimated $489K.
  • Polar Capital first reported a position in Standard BioTools in Q2 2014 and held it in 9 quarters.
  • Polar Capital's Standard BioTools position peaked at $786K in Q1 2015.
  • 98 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2016.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.